Dementia
Study links carbohydrate quality to dementia risk in UK Biobank cohort
Von KI berichtet Bild generiert von KI Fakten geprüft
A long-term analysis of more than 200,000 UK Biobank participants found that diets with lower glycemic index values were associated with a lower risk of dementia, including Alzheimer’s disease and vascular dementia, while higher dietary glycemic load was tied to a higher risk.
A large study of nearly 2 million older adults has found that cerebral amyloid angiopathy, a condition where amyloid proteins build up in brain blood vessels, sharply increases the risk of dementia. Within five years of diagnosis, people with this disorder were four times more likely to develop dementia than those without it, even absent a history of stroke. The findings, drawn from Medicare records, underscore the need for early cognitive screening in affected individuals.
Von KI berichtet
Scientists have created innovative nanoparticles designed to destroy harmful proteins linked to dementia and cancer. These particles can access difficult tissues like the brain and precisely eliminate problematic proteins without broad side effects. The technology shows early promise for precision medicine.
Alzheimer's trials are shifting to a multi-target approach inspired by cancer research, even after failures with Novo Nordisk's semaglutide. Only two drugs, Eli Lilly's Kisunla and Eisai and Biogen's Leqembi, are widely approved to slow progression. This evolution treats the brain-wasting disease as a complex system, seeking new ways to halt it amid its global impact.
Von KI berichtet Fakten geprüft
Researchers in Germany have identified a rare mutation in the GPX4 enzyme that disables its protective role in neurons, allowing toxic lipid peroxides to damage cell membranes and trigger ferroptotic cell death. Studies in patient-derived cells and mice show a pattern of neurodegeneration that resembles changes seen in Alzheimer’s disease and other dementias.
Washington University scientists report that inhibiting the circadian regulator REV-ERBα raised brain NAD+ and reduced tau pathology in mouse models, pointing to a clock-focused strategy worth exploring for Alzheimer’s disease.
Von KI berichtet Fakten geprüft
A double‑blind McGill University–led clinical trial reports that 10 weeks of BrainHQ exercises increased a PET marker of cholinergic function in healthy older adults by an amount the authors say roughly offsets about a decade of age‑related decline. The peer‑reviewed study used a specialized tracer to confirm the biochemical change.
Study finds obesity and high blood pressure directly cause dementia
Mittwoch, 14. Januar 2026, 06:26 UhrStudy finds risky drugs still prescribed to millions with dementia
Sonntag, 04. Januar 2026, 02:06 UhrWeaker circadian “body clocks” in older adults tied to higher dementia risk, study finds
Samstag, 03. Januar 2026, 12:49 UhrMRI-visible enlarged perivascular spaces linked to early Alzheimer’s biomarkers in Singapore study
Donnerstag, 25. Dezember 2025, 07:36 UhrScientists restore brain blood flow in dementia model
Samstag, 06. Dezember 2025, 00:34 UhrKidney problems may skew Alzheimer’s blood test results, study suggests
Mittwoch, 03. Dezember 2025, 22:51 UhrShingles vaccine associated with lower dementia risk in large Welsh study
Montag, 17. November 2025, 22:52 UhrListening to music in later life tied to lower dementia risk, large Monash study finds
Dienstag, 11. November 2025, 17:07 UhrStudy finds lecanemab clears amyloid but shows no short-term recovery in brain waste-clearance system
Donnerstag, 06. November 2025, 18:43 UhrAstrocyte mitochondrial free radicals tied to dementia pathology in mice